前列腺癌的实验室诊断研究进展
摘要
前列腺癌是泌尿系统常见的恶性肿瘤之一,近年来其发病率在我国有上升趋势,早期诊断非常重要。本文从免疫学和分子生物学角度阐述前列腺癌实验室有价值的诊断指标及其最新进展。
出处
《国际检验医学杂志》
CAS
2006年第2期146-148,151,共4页
International Journal of Laboratory Medicine
参考文献16
-
1Zhang WM,Finne P,Leinonen J,et al.Characterization and immunological determination of the complex between prostate-specific antigen and alpha2-macroglobulin.Clin Chem,1998,44 (12):2471-2479.
-
2Jung K,Elgeti U,Lein M,et al.Ratio of free or complexed prostate-specific antigen (PSA) to total PSA:which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer? Clin Chem,2000,46(1):55-62.
-
3Stancik I,Luftenegger W,Klimpfinger M,et al.Effect of NIH-IV prostatitis on free and free-to-total PSA.Eur Urol,2004,46 (6):760-764.
-
4Straub B,Muller M,Krause H,et al.Quantitative real-time rtPCR for detection of circulating prostate-specific antigen mRNA using sequence-specific oligonucleotide hybridization probes in prostate cancer patients.Oncology,2003,65(Suppl 1):12-17.
-
5O'Keefe DS,Bacich DJ,Heston WD.Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene.Prostate,2004,58(2):200-210.
-
6Zhang W,Kapusta LR,Slingerland JM,et al.Telomerase activity in prostate cancer,prostatic intraepithelial neoplasia,and benign prostatic epithelium.Cancer Res,1998,58(4):619-621.
-
7De-Kok JB,Schalken JA,Aalders TW,et al.Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas.Int J Cancer,2000,87(2):217-220.
-
8Bieche I,Nogues C,Paradis V,et al.Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.Clin Cancer Res,2000,6(2):452-459.
-
9Crocitto LE,Korns D,Kretzner L,et al.Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results.Urology,2004,64(4):821-825.
-
10Black MH,Magklara A,Obiezu C,et al.Expression of a prostateassociated protein,human glandular kallikrein (hK2),in breast tumours and in normal breast secretions.Br J Cancer,2000,82(2):361-367.
-
1郝润英,张书霞,栗瑞敏,王菊美.影响多发性骨髓瘤疗效和预后的实验室指标分析[J].国际检验医学杂志,2012,33(23):2836-2837. 被引量：4
-
2杜红心,罗海峰,彭必江,陈蓉,程钢,林岚.联合检测CEA、NSE和CYFRA21-1在肺癌诊断中的价值[J].国际检验医学杂志,2010,31(5):447-448. 被引量：13
-
3王庆,冯丽伟,熊旭东.以恶心、呕吐为主要表现的多发性骨髓瘤1例[J].临床荟萃,2012,27(16):1470-1470.
-
4谢奇朋,余坚,陈晓晴,温怀凯.血清miRNA141和miRNA375在前列腺癌诊断中的意义[J].中华全科医师杂志,2015,0(3):228-230. 被引量：2
-
5李拓,刘志民.甲状腺结节诊断方法的研究进展[J].临床荟萃,2013,28(4):460-463. 被引量：4
-
6杜琼,文慧,杨明清.孕妇TORCH核酸检测及意义[J].陕西医学检验,1998,13(4):1-2.
-
7毛晓露,陶志华,陈晓东.前列腺癌的实验室诊断进展[J].检验医学教育,2004,11(3):41-45.
-
8刘春青,赵际起,薛涛.青年人胃癌误诊21例分析[J].临床荟萃,2006,21(18):1365-1365. 被引量：3
-
9张金凤,于玲,姜桂.实验室检查在多发性骨髓瘤诊断中的临床意义[J].肿瘤防治杂志,2003,10(10):1101-1101. 被引量：2
-
10李勇,张叶青.血清和腹腔积液中唾液酸、癌胚抗原和铁蛋白联检对肝癌诊断价值的探讨[J].淮海医药,2008,26(5):410-411.
